logo
Select company
Select metric
$ 147.13MInvested Capital
VS
Market
30
Sector
51
Industry
59
History
21
$ 14.01Close
$ 2.29 - $ 18.94 52-Week Range
Ticker Information

Ticker

PHAT

Company Name

PHATHOM PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PHATHOM PHARMACEUTICALS INC - Invested Capital Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PHAT - Inv. Capital Historical data
DateTotal DebtShareholders EquityInvested Capital
6/30/2025$ 552.97M$ -405.83M$ 147.13M
3/31/2025$ 547.37M$ -338.38M$ 208.99M
12/31/2024$ 535.17M$ -253.58M$ 281.59M
9/30/2024$ 498.8M$ -187.11M$ 311.69M
6/30/2024$ 496.47M$ -233.83M$ 262.64M
3/31/2024$ 452.57M$ -148.5M$ 304.07M
12/31/2023$ 438.85M$ -72.76M$ 366.09M
9/30/2023$ 224.01M$ -17.77M$ 206.23M
6/30/2023$ 219.11M$ 17.6M$ 236.71M
3/31/2023$ 212.97M$ -90.19M$ 122.78M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PHATHOM PHARMACEUTICALS INC's latest trailing twelve months (TTM) Inv. Capital stands at $ 205.08M.
  • Over the past 5 years, PHATHOM PHARMACEUTICALS INC's average Inv. Capital has been $ 213.44M.
  • The median Inv. Capital for PHATHOM PHARMACEUTICALS INC during this period was $ 205.66M
  • PHATHOM PHARMACEUTICALS INC reached its highest Inv. Capital over the past 5 years at $ 366.09M.
  • The lowest Inv. Capital recorded by PHATHOM PHARMACEUTICALS INC in the same timeframe $ 122.78M

PHATHOM PHARMACEUTICALS INC's Inv. Capital vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Inv. Capital Benchmarks
CompanyInv. Capital
GYRE : GYRE THERAPEUTICS INC $ 93.42MANAB : ANAPTYSBIO INC $ 301.72MNAGE : NIAGEN BIOSCIENCE INC $ 67.49MCRMD : CORMEDIX INC $ 221.07MTBPH : THERAVANCE BIOPHARMA INC $ 271.31MZYME : ZYMEWORKS INC $ 353.18MURGN : UROGEN PHARMA LTD $ 32.55MZVRA : ZEVRA THERAPEUTICS INC $ 179.51MXNCR : XENCOR INC $ 833.3MKURA : KURA ONCOLOGY INC $ 324.96M

Definition of Invested Capital

[Calculation] Invested Capital is the total amount of money raised by a business in the form [Equity] and/or [Debt].
Debt + Equity
(=) Inv. Capital
Inv. Capital for PHATHOM PHARMACEUTICALS INC is calculated as follows: Debt [ $ 48.69M ] + Equity [ $ 156.39M ]
(=) Inv. Capital [ $ 205.08M ]

PHAT - Invested Capital, Last 5 years

$ 122.78M

Minimum

Mar 31, 2023

$ 366.09M

Maximum

Dec 31, 2023

$ 213.44M

Average

$ 205.66M

Median

Inv. Capital Benchmark Analysis

The chart above depicts the distribution of Inv. Capital for companies in the Total Stock Market. The average Inv. Capital of the companies is $ 759.87M with a standard deviation of $ 1B.
The following table provides additional summary stats:
Inv. Capital in the Market:
filtered constituents3.44K
min$ -1.51B
max$ 4.11B
average$ 759.87M
median$ 302.55M
std$ 1B